The efficacy and safety of a fixed versus titrated dosage regimen of nicotine gum for smoking cessation or reduction in pregnancy

2006 ◽  
Vol 195 (6) ◽  
pp. S89 ◽  
Author(s):  
Cheryl Oncken ◽  
Bruce Morris ◽  
Ellen Dornelas ◽  
Henry Kranzler ◽  
Stephen Walsh ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Dosage Regimen ◽  
Nicotine Gum ◽  
Efficacy And Safety ◽  
In Pregnancy

Smoking cessation in pregnancy: An observational study

2015 ◽  
Vol 5 (2) ◽  
pp. 43-48
Author(s):  
Pauline Kent ◽  
Mette Jensen ◽  
Rachel Reilly ◽  
Amy McGowan ◽  
Leanne Dineen ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Observational Study ◽  
In Pregnancy

scholarly journals Current and Emerging Pharmacotherapeutic Options for Smoking Cessation

2013 ◽  
Vol 7 ◽  
pp. SART.S8108 ◽  
Author(s):  
Kristin V. Carson ◽  
Malcolm P. Brinn ◽  
Thomas A. Robertson ◽  
Rachada To-A-Nan ◽  
Adrian J. Esterman ◽  
...  
Keyword(s):  
Developing Countries ◽  
Smoking Cessation ◽  
Clinical Practice ◽  
Chronic Disease ◽  
Developed Countries ◽  
Mental Illnesses ◽  
Current Clinical Practice ◽  
Efficacy And Safety ◽  
First Line ◽  
Marginalized Groups

Tobacco smoking remains the single most preventable cause of morbidity and mortality in developed countries and poses a significant threat across developing countries where tobacco use prevalence is increasing. Nicotine dependence is a chronic disease often requiring multiple attempts to quit; repeated interventions with pharmacotherapeutic aids have become more popular as part of cessation therapies. First-line medications of known efficacy in the general population include varenicline tartrate, bupropion hydrochloride, nicotine replacement therapy products, or a combination thereof. However, less is known about the use of these products in marginalized groups such as the indigenous, those with mental illnesses, youth, and pregnant or breastfeeding women. Despite the efficacy and safety of these first line pharmacotherapies, many smokers continue to relapse and alternative pharmacotherapies and cessation options are required. Thus, the aim of this review is to summarize the existing and developing pharmacotherapeutic and other options for smoking cessation, to identify gaps in current clinical practice, and to provide recommendations for future evaluations and research.

Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy

Addiction ◽  
2001 ◽  
Vol 96 (3) ◽  
pp. 485-494 ◽  
Author(s):  
Peter Hajek ◽  
Robert West ◽  
Anne Lee ◽  
Jonathan Foulds ◽  
Lesley Owen ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Controlled Trial ◽  
Smoking Cessation Intervention ◽  
Randomized Controlled ◽  
Cessation Intervention ◽  
In Pregnancy

Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy

Drug Safety ◽  
2001 ◽  
Vol 24 (4) ◽  
pp. 277-322 ◽  
Author(s):  
Delia A. Dempsey ◽  
Neal L. Benowitz
Keyword(s):  
Smoking Cessation ◽  
Risks And Benefits ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document